Search Result "alirocumab"


Letter to the Editor

Alirocumab in post ACS Patients - Saving Lives at a Premium

Journal: Current Cardiology Reviews
Volume: 17 Issue: 0 Year: 2021 Page: 1-2
Author(s): Melvin George,Luxitaa Goenka

Review Article

Anti-PCSK9 Antibodies: A New Era in the Treatment of Dyslipidemia

Journal: Current Pharmaceutical Design
Volume: 23 Issue: 1 Year: 2017 Page: 1484-1494
Author(s): Joel Schmitz,Ioanna Gouni-Berthold

Review Article

Role of PCSK9 Inhibitors in High Risk Patients with Dyslipidemia: Focus on Familial Hypercholesterolemia

Journal: Current Pharmaceutical Design
Volume: 24 Issue: 3 Year: 2018 Page: 3647-3653
Author(s): Vasilios Papademetriou,Konstantinos Stavropoulos,Christodoulos Papadopoulos,Konstantinos Koutsampasopoulos,Kiriakos Dimitriadis,Kostas Tsioufis

Familial Hypercholesterolemia: Etiology, Diagnosis and New Treatment Options

Journal: Current Pharmaceutical Design
Volume: 20 Issue: 4 Year: 2014 Page: 6220-6229
Author(s): Ioanna Gouni-Berthold, Heiner K. Berthold

Review Article

Treatment with Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors to Reduce Cardiovascular Inflammation and Outcomes

Journal: Current Medicinal Chemistry
Volume: 24 Issue: 1 Year: 2017 Page: 1403-1416
Author(s): Luca Liberale,Fabrizio Montecucco,Giovanni G. Camici,Franco Dallegri,Alessandra Vecchie,Federico Carbone,Aldo Bonaventura

Review Article

Role of Anti-PCSK9 Antibodies in the Treatment of Patients with Statin Intolerance

Journal: Current Medicinal Chemistry
Volume: 25 Issue: 1 Year: 2018 Page: 1538-1548
Author(s): Julia Schreml,Ioanna Gouni-Berthold

Review Article

A Review of PCSK9 Inhibitors and their Effects on Cardiovascular Diseases

Journal: Current Topics in Medicinal Chemistry
Volume: 19 Issue: 2 Year: 2019 Page: 1790-1817
Author(s): Bo Chen,Xin Shi,Yanping Cui,Aiping Hou,Pengjun Zhao

Review Article

Proprotein Convertase Subtilisin/Kexin type 9 (PCSK9): Impact of PCSK9 on Major Adverse Cardiac and Cerebrovascular Events

Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 14 Issue: 2 Year: 2016 Page: 94-100
Author(s): Muharrem Akin,Thomas Skripuletz,L. Christian Napp,Dominik Berliner,Ibrahim Akin,Arash Haghikia,Elvan Akin,Johann Bauersachs

Hypolipidaemic Drug Treatment: Yesterday is Not Gone Yet, Today is Challenging and Tomorrow is Coming Soon; let us Combine them all

Journal: Current Pharmaceutical Design
Volume: 20 Issue: 4 Year: 2014 Page: 6350-6357
Author(s): Vasilios G. Athyros, Konstantinos Tziomalos, Asterios Karagiannis, Dimitri P. Mikhailidis

Review Article

Drugs that Mimic the Effect of Gene Mutations for the Prevention or the Treatment of Atherosclerotic Disease: From PCSK9 Inhibition to ANGPTL3 Inactivation

Journal: Current Pharmaceutical Design
Volume: 24 Issue: 3 Year: 2018 Page: 3638-3646
Author(s): Vasilios G. Athyros,Niki Katsiki,Aikaterini Dimakopoulou,Dimitrios Patoulias,Sofia Alataki,Michael Doumas

Previous   Next

Go To   Results 1 - 1 of 57

Filter Result

Volume Year
Ads
© 2022 Bentham Science Publishers | Privacy Policy